Search

everythinglearnresearchcommunity

for

Search:↓

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

A horse in Brazil had seasonal hair loss possibly linked to light exposure and melatonin levels.

The document concludes that scalp conditions have various causes and can present in many different ways.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Transverse sections are better for non-scarring hair loss, vertical sections are better for lichen planopilaris, and either method works for other scarring hair loss types.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Triamcinolone regrows hair better but relapses more than anthralin.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Treatment with methotrexate and prednisolone led to complete hair regrowth and no relapse for 2 years.

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

DPCP is effective for treating severe alopecia areata, but relapse is common.